​

NRx Pharmaceuticals (NRXP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NRXP Stock Forecast

NRx Pharmaceuticals (NRXP) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a -41.86% decline from the last price of $3.44.

High: $2 Avg: $2 Low: $2 Last Closed Price: $3.44

NRXP Stock Rating

NRx Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

NRXP Price Target Upside V Benchmarks

TypeNameUpside
StockNRx Pharmaceuticals-41.86%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.44$3.44$3.44
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-3---3
May, 2513---4
Apr, 2512---3
Mar, 2512---3
Feb, 2512---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 30, 2022Vernon BernardinoH.C. Wainwright$2.00$0.57250.88%-41.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2025BTIGBuyinitialise
Oct 21, 2024EF HuttonBuyinitialise
Aug 02, 2024H.C. WainwrightBuyBuyhold
Jun 30, 2022H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-5 $0 $5 $10 $15 $20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.98$-2.39----
Avg Forecast$-2.92$-1.86$0.32$1.12$4.06$8.71
High Forecast$-1.77$-0.79$0.56$1.94$7.05$15.12
Low Forecast$-4.07$-3.22$0.14$0.48$1.73$3.70
Surprise %36.30%28.49%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$6.70M$68.47M$180.28M$518.62M$1.05B
High Forecast-$10.49M$107.21M$282.30M$812.11M$1.65B
Low Forecast-$3.74M$38.20M$100.57M$289.32M$588.07M
Surprise %------

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.15M$-25.13M----
Avg Forecast$-30.16M$-20.39M$2.62M$9.17M$33.23M$65.99M
High Forecast$-13.42M$-5.98M$4.21M$14.73M$53.39M$114.53M
Low Forecast$-30.82M$-24.41M$1.03M$3.61M$13.08M$28.06M
Surprise %-0.03%23.23%----

NRXP Forecast FAQ

Is NRx Pharmaceuticals stock a buy?

NRx Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NRx Pharmaceuticals is a favorable investment for most analysts.

What is NRx Pharmaceuticals's price target?

NRx Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential -41.86% change from the previous closing price of $3.44.

How does NRx Pharmaceuticals stock forecast compare to its benchmarks?

NRx Pharmaceuticals's stock forecast shows a -41.86% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for NRx Pharmaceuticals over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NRx Pharmaceuticals’s EPS forecast?

NRx Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.32, marking a -113.39% decrease from the reported $-2.39 in 2024. Estimates for the following years are $1.12 in 2026, $4.06 in 2027, and $8.71 in 2028.

What is NRx Pharmaceuticals’s revenue forecast?

NRx Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $68.47M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $180.28M, followed by $518.62M for 2027, and $1.05B for 2028.

What is NRx Pharmaceuticals’s net income forecast?

NRx Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $2.62M, representing a -110.43% decrease from the reported $-25.126M in 2024. Projections indicate $9.17M in 2026, $33.23M in 2027, and $65.99M in 2028.